| Share-based Payment Arrangement, Option, Activity |
A summary of the employees’ stock option activity is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited) |
Number of options |
|
Weighted-average exercise price |
|
Remaining contractual term |
|
Aggregate intrinsic value |
Outstanding at December 31, 2020 |
9,112,121
|
|
|
$ |
0.49
|
|
|
7.20 |
|
$ |
3,100 |
| Granted |
1,109,750 |
|
|
3.76 |
|
|
|
|
|
| Exercised |
(1,899,793) |
|
|
0.29 |
|
|
|
|
|
| Forfeited |
(163,330) |
|
|
1.18 |
|
|
|
|
|
| Expired |
(47,943) |
|
|
0.79 |
|
|
|
|
|
Outstanding at September 30, 2021 |
8,110,805
|
|
|
$ |
0.97
|
|
|
5.86 |
|
$ |
65,412 |
Exercisable at September 30, 2021 |
4,867,399
|
|
|
$ |
0.50
|
|
|
4.50 |
|
$ |
41,511 |
A summary of the consultants’ stock option activity under the Plan is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Unaudited) |
Number of options |
|
Weighted-average exercise price |
|
Remaining contractual term |
|
Aggregate intrinsic value |
Outstanding at December 31, 2020 |
762,248
|
|
|
$ |
0.68
|
|
|
6.32 |
|
$ |
213 |
| Granted |
154,502 |
|
|
3.76 |
|
|
|
|
|
| Exercised |
(201,799) |
|
|
1.67 |
|
|
|
|
|
| Forfeited |
(20,625) |
|
|
0.82 |
|
|
|
|
|
Outstanding at September 30, 2021 |
694,326
|
|
|
$ |
1.08
|
|
|
6.46 |
|
$ |
5,523 |
Exercisable at September 30, 2021 |
469,659
|
|
|
$ |
0.78
|
|
|
5.72 |
|
$ |
3,876 |
A summary of the employees’ stock option activity under the Plan for the years ended December 31, 2020 and 2019 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
December 31, 2020
|
|
|
|
Amount
of
options
|
|
Weighted
average
exercise
price
|
|
Weighted
average
remaining contractual term
(in years)
|
|
Aggregate intrinsic value (in thousands) |
Outstanding at beginning of year
|
6,721,339
|
|
|
$ |
0.58
|
|
|
7.30 |
|
$ |
1,758
|
|
| Granted |
3,698,500 |
|
|
0.82 |
|
|
|
|
|
| Forfeited |
(814,952) |
|
|
0.85 |
|
|
|
|
|
| Expired |
(413,678) |
|
|
0.55 |
|
|
|
|
|
| Exercised |
(79,088) |
|
|
0.68 |
|
|
|
|
|
Outstanding at end of year
|
9,112,121
|
|
|
$ |
0.49
|
|
|
7.20 |
|
$ |
3,100
|
|
Exercisable options at end of year
|
4,567,670
|
|
|
$ |
0.50
|
|
|
4.80 |
|
$ |
2,301
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, 2019 |
|
|
|
Amount
of
options
|
|
Weighted
average
exercise
price
|
|
Weighted
average
remaining contractual term
(in years)
|
|
Aggregate intrinsic value (in thousands) |
Outstanding at beginning of year
|
5,474,026
|
|
|
$ |
0.52
|
|
|
7.42 |
|
$ |
1,920
|
|
| Granted |
1,765,665 |
|
|
0.85 |
|
|
|
|
|
| Forfeited |
(213,705) |
|
|
0.82 |
|
|
|
|
|
| Expired |
(144,386) |
|
|
0.74 |
|
|
|
|
|
| Exercised |
(160,261) |
|
|
0.62 |
|
|
|
|
|
Outstanding at end of year
|
6,721,339
|
|
|
$ |
0.58
|
|
|
7.30 |
|
$ |
1,758
|
|
Exercisable options at end of year
|
4,274,687
|
|
|
$ |
0.45
|
|
|
6.02 |
|
$ |
1,725
|
|
A summary of the consultants’ stock option activity under the Plan for the years ended December 31, 2020 and 2019 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended
December 31, 2020
|
|
|
|
Amount
of
options
|
|
Weighted
average
exercise
price
|
|
Weighted
average
remaining contractual term
(in years)
|
|
Aggregate intrinsic value (in thousands) |
Outstanding at beginning of year
|
722,248
|
|
|
$ |
0.57
|
|
|
5.30 |
|
$ |
201 |
|
| Granted |
340,000 |
|
|
0.53 |
|
|
|
|
|
| Expired |
(150,000) |
|
|
0.16 |
|
|
|
|
|
| Exercised |
(150,000) |
|
|
0.16 |
|
|
|
|
|
Outstanding at end of year
|
762,248
|
|
|
$ |
0.68
|
|
|
6.32 |
|
$ |
213 |
|
Exercisable options at end of year
|
491,205
|
|
|
$ |
0.65
|
|
|
5.20 |
|
$ |
170 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, 2019 |
|
|
|
Amount
of
options
|
|
Weighted
average
exercise
price
|
|
Weighted
average
remaining contractual term
(in years)
|
|
Aggregate intrinsic value (in thousands) |
Outstanding at beginning of year
|
682,248
|
|
|
$ |
0.52
|
|
|
9.50 |
|
$ |
1,920 |
|
| Granted |
40,000 |
|
|
0.85 |
|
|
|
|
|
Outstanding at end of year
|
722,248
|
|
|
$ |
0.57
|
|
|
5.30 |
|
$ |
201 |
|
Exercisable options at end of year
|
586,622
|
|
|
$ |
—
|
|
|
4.56 |
|
$ |
197 |
|
|
| Schedule Share Based Compensation Expenses |
A summary of the employees’ stock option activity under the Plan for the nine months ending September 30, 2021 (unaudited) and 2020 (unaudited) is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, |
|
2021 |
|
2020 |
|
Unaudited |
|
Unaudited |
Cost of goods sold |
$ |
34 |
|
|
$ |
10 |
|
Research and development |
319 |
|
|
113 |
|
Sales and marketing |
400 |
|
|
261 |
|
General and administrative |
1,285 |
|
|
33 |
|
Total
|
$ |
2,038
|
|
|
$ |
417
|
|
During the years ended December 31, 2020 and 2019, the Company recorded stock-based compensation expenses for the employees as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, |
|
2020 |
|
2019 |
Cost of goods sold |
$ |
11 |
|
|
$ |
6 |
|
Research and development |
121 |
|
|
77 |
|
Sales and marketing |
196 |
|
|
200 |
|
General and administrative |
92 |
|
|
43 |
|
Total
|
$ |
420
|
|
|
$ |
326
|
|
|